Feedback / Questions
Hadlima (adalimumab-bwwd) - Organon, Biogen, Samsung, Mundipharma, Yuhan Corp
Epysqli (eculizumab-aagh) - AffaMed Therap, Samsung, Teva
Bkemv (eculizumab-aeeb) - Amgen
Pyzchiva (ustekinumab-ttwe) - Samsung, Sandoz, NIPRO Corp
https://www.businesswire.com/news/home/20260427670459/en/Samsung-Bioepis-Releases-Second-Quarter-2026-US-Biosimilar-Market-Report
Apr 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next